Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Johnson & Johnson Q3 earnings, revenue beat expectations

Published 10/14/2014, 07:54 AM
Updated 10/14/2014, 07:54 AM

Investing.com - Health care conglomerate Johnson & Johnson (NYSE:JNJ) reported better-than-expected third quarter earnings on the back of strong revenue figures, it announced early Tuesday.

J&J said earnings per share came in at $1.50 in the three months ending September 30, beating expectations for earnings of $1.44 per share.

The company’s third quarter revenue totaled $18.47 billion, above expectations for revenue of $17.57 billion.

Domestic sales increased 11.6%, while international sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%.

Worldwide, domestic and international operational sales growth, excluding the impact of this divestiture, was 8.4%; 14.8% and 3.1% respectively.

"Our strong third-quarter performance reflects the continued success of our new products and the strength of our core business. We are making deliberate portfolio choices, positioning us well for achieving our near-term priorities and our long-term growth drivers," said Alex Gorsky, Chairman and Chief Executive Officer.

The firm now sees full year adjusted earnings per share in a range between $5.92 and $5.97, up from a previous estimate for adjusted earnings between $5.85 and $5.92 per share.

Immediately after the earnings announcement, JNJ shares rose 1.4% in trading prior to the opening bell.

Meanwhile, the outlook for U.S. equity markets was modestly higher. The Dow 30 futures indicated a gain of 0.2%, the S&P 500 pointed to a rise of 0.3%, while the tech-heavy NASDAQ 100 indicated an increase of 0.3%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.